118 related articles for article (PubMed ID: 8905573)
1. A lipopolysaccharide-induced acute phase response in the pig is associated with a decrease in hepatic cytochrome P450-mediated drug metabolism.
Monshouwer M; Witkamp RF; Nijmeijer SM; Van Leengoed LA; Vernooy HC; Verheijden JH; Van Miert AS
J Vet Pharmacol Ther; 1996 Oct; 19(5):382-88. PubMed ID: 8905573
[TBL] [Abstract][Full Text] [Related]
2. The suppressive effects of lipopolysaccharide-induced acute phase response on hepatic cytochrome P450-dependent drug metabolism in rabbits.
Saitoh T; Kokue E; Shimoda M
J Vet Pharmacol Ther; 1999 Apr; 22(2):87-95. PubMed ID: 10372593
[TBL] [Abstract][Full Text] [Related]
3. Infection (Actinobacillus pleuropneumoniae)-mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRNA levels in pigs.
Monshouwer M; Witkamp RF; Nijmeijer SM; Van Leengoed LA; Verheijden JH; Van Miert AS
Drug Metab Dispos; 1995 Jan; 23(1):44-7. PubMed ID: 7720523
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of decrease in levels of hepatic P450 isozymes induced by intracerebral endotoxin: independence from sympathetic nervous and adrenocortical systems.
Shimamoto Y; Kitamura H; Iwai M; Saito M; Kazusaka A; Fujita S
Arch Toxicol; 1999 Feb; 73(1):41-9. PubMed ID: 10207613
[TBL] [Abstract][Full Text] [Related]
5. Differential alterations in levels of hepatic microsomal cytochrome P450 isozymes following intracerebroventricular injection of bacterial lipopolysaccharide in rats.
Shimamoto Y; Kitamura H; Hoshi H; Kazusaka A; Funae Y; Imaoka S; Saito M; Fujita S
Arch Toxicol; 1998; 72(8):492-8. PubMed ID: 9765064
[TBL] [Abstract][Full Text] [Related]
6. Effects of intravenous administration of lipopolysaccharide on cytochrome P450 isoforms and hepatic drug metabolizing enzymes in swine.
Myers MJ; Farrell DE; Howard KD; Kawalek JC
Am J Vet Res; 2010 Mar; 71(3):342-8. PubMed ID: 20187837
[TBL] [Abstract][Full Text] [Related]
7. Effect of cobalt protoporphyrin on hepatic drug-metabolizing enzymes. Specificity for cytochrome P-450.
Spaethe SM; Jollow DJ
Biochem Pharmacol; 1989 Jun; 38(12):2027-38. PubMed ID: 2742604
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism.
Shedlofsky SI; Israel BC; McClain CJ; Hill DB; Blouin RA
J Clin Invest; 1994 Dec; 94(6):2209-14. PubMed ID: 7989576
[TBL] [Abstract][Full Text] [Related]
9. Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain.
Renton KW; Nicholson TE
J Pharmacol Exp Ther; 2000 Aug; 294(2):524-30. PubMed ID: 10900228
[TBL] [Abstract][Full Text] [Related]
10. Effect of dietary ascorbic acid on the hepatic microsomal mixed function oxidase system in liver of chicks treated with Escherichia coli lipopolysaccharide.
Takahashi K; Akiba Y; Tamura K
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1997 Nov; 118(3):301-4. PubMed ID: 9467882
[TBL] [Abstract][Full Text] [Related]
11. Effect of rociverine on P450-dependent monooxygenases and its N-deethylation metabolism in rat liver microsomes.
Menicagli S; Lippi A; Criscuoli M; Gervasi PG
Biochem Pharmacol; 1993 Mar; 45(5):1097-105. PubMed ID: 8461039
[TBL] [Abstract][Full Text] [Related]
12. The regulation of cytochrome P450 2E1 during LPS-induced inflammation in the rat.
Abdulla D; Goralski KB; Renton KW
Toxicol Appl Pharmacol; 2006 Oct; 216(1):1-10. PubMed ID: 16712892
[TBL] [Abstract][Full Text] [Related]
13. Depression of hepatic drug metabolism in endotoxin-treated and sarcoma-bearing mice.
Bertini R; Gervasi PG; Longo V; Ghezzi P
Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):223-31. PubMed ID: 1604046
[TBL] [Abstract][Full Text] [Related]
14. Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat.
Chen YL; Florentin I; Batt AM; Ferrari L; Giroud JP; Chauvelot-Moachon L
Biochem Pharmacol; 1992 Jul; 44(1):137-48. PubMed ID: 1632828
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
16. Putrescine decreases cytochrome P450 3A4 levels during liver regeneration in the rat.
Favre C; Monti JA; Scapini C; Pellegrino J; Carnovale CE; Carrillo MC
J Hepatol; 1998 Apr; 28(4):700-8. PubMed ID: 9566840
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of B- and T-lymphocyte mitogens on cytochrome P450 in mice.
Jeong HG
Toxicol Lett; 1999 Jan; 104(1-2):57-64. PubMed ID: 10048750
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 and antioxidant activity in interleukin-6 knockout mice after induction of the acute-phase response.
Warren GW; van Ess PJ; Watson AM; Mattson MP; Blouin RA
J Interferon Cytokine Res; 2001 Oct; 21(10):821-6. PubMed ID: 11710994
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro effects of helenalin on mouse hepatic microsomal cytochrome P450.
Chapman DE; Holbrook DJ; Chaney SG; Hall IH; Lee KH
Biochem Pharmacol; 1991 Jan; 41(2):229-35. PubMed ID: 1989634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
